ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$VKTX:NASDAQ · VIKING THERAPEUTICS INC

Sector: health

Conviction from: NASDAQ

Tradable on: Bitget →

52-week range: 23.8243.10

Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies for metabolic and endocrine disorders, including obesity and liver disease.

6 tracked filer(s) hold this · 2 opened, 1 added, 2 trimmed in 30-SEP-2026

Aggregate 13FScore 60 — mean of 6 scored holder(s) · buyers (new/add) avg 63. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy7,750,000$7,864,6990.0%
Louis Bacon / Moore52New buy67,549$2,202,0970.0%
Paul Tudor Jones / Tudor61Added +13%324,642$10,583,3290.0%
Ancora42Holds (flat)570$18,5820.0%
Steve Cohen / Point7275Trimmed -69%155,216$5,060,0420.0%
Bridgewater55Trimmed -5%83,172$2,711,4070.0%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#134 — Citrini Therapeutics: We Wanted to Use Claude to Create a New Drug2026-10-20WATCH

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.